Boosting anti-tumor immunity with TILT-517 oncolytic adenovirus and checkpoint blockade in renal cell carcinoma.

Arias V, Kudling TV, Clubb JHA, Jirovec E, Pakola SA, Van der Heijden M, Basnet S, Quixabeira DCA, Haybout L, Ojala N, Grönberg-Vähä-Koskela S, Kanerva A, Rannikko A, Santos JM, Cervera-Carrascon V, Hemminki O, Hemminki A

Open source

DOI: 10.1016/j.omton.2025.200979
Published: 2025 Jun 18
Container: Molecular therapy. Oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.omton.2025.200979,
  title = {Boosting anti-tumor immunity with TILT-517 oncolytic adenovirus and checkpoint blockade in renal cell carcinoma.},
  author = {Arias V and Kudling TV and Clubb JHA and Jirovec E and Pakola SA and Van der Heijden M and Basnet S and Quixabeira DCA and Haybout L and Ojala N and Grönberg-Vähä-Koskela S and Kanerva A and Rannikko A and Santos JM and Cervera-Carrascon V and Hemminki O and Hemminki A},
  year = {2025},
  journal = {Molecular therapy. Oncology},
  doi = {10.1016/j.omton.2025.200979},
  url = {https://doi.org/10.1016/j.omton.2025.200979}
}

RIS

TY  - JOUR
TI  - Boosting anti-tumor immunity with TILT-517 oncolytic adenovirus and checkpoint blockade in renal cell carcinoma.
AU  - Arias V
AU  - Kudling TV
AU  - Clubb JHA
AU  - Jirovec E
AU  - Pakola SA
AU  - Van der Heijden M
AU  - Basnet S
AU  - Quixabeira DCA
AU  - Haybout L
AU  - Ojala N
AU  - Grönberg-Vähä-Koskela S
AU  - Kanerva A
AU  - Rannikko A
AU  - Santos JM
AU  - Cervera-Carrascon V
AU  - Hemminki O
AU  - Hemminki A
PY  - 2025
JO  - Molecular therapy. Oncology
DO  - 10.1016/j.omton.2025.200979
UR  - https://doi.org/10.1016/j.omton.2025.200979
ER  -

APA

V, A., TV, K., JHA, C., E, J., SA, P., M, V. D. H., S, B., DCA, Q., L, H., N, O., S, G., A, K., A, R., JM, S., V, C., O, H., & A, H. (2025). Boosting anti-tumor immunity with TILT-517 oncolytic adenovirus and checkpoint blockade in renal cell carcinoma.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2025.200979

Source records

pubmed · retrieved 2026-09-26T06:08:11.792Z